Abstract: Provided are a scalable analog passive intermodulation (PIM) module, a method of controlling analog PIM, a signal processing circuit, and a sensor device. The scalable analog PIM module includes a first plural number of digital-to-analog converters (DACs), a first plural number of static random access memory (SRAM) calculators connected to the first plural number of DACs, at least one analog-to-digital converter (ADC) connected to the first plural number of SRAM calculators and configured to convert an analog convolution result signal into digital convolution data, and an analog PIM controller configured to output an enable control signal for enabling a second number, which is equal to or less than first plural number, of SRAM calculators among the first plural number of SRAM calculators to the first plural number of SRAM calculators on the basis of the convolution data output from the ADC.

Abstract: A system for disease diagnosis includes a patch neural network for generating a patch-level diagnostic result of whether or not a disease is present in each of predetermined patches formed by dividing a slide into a predetermined size; a heat map generation module for generating a patch-level heat map image corresponding to the biometric image obtained from the slide on the basis of the patch diagnostic results of the respective multiple patches included in the slide; a tissue mask generation module for generating a tissue mask image corresponding to the biometric image obtained from the slide on the basis of a hue-saturation-value (HSV) model corresponding to the slide; and a visualization module for generating a disease diagnostic visualization image corresponding to the biometric image obtained from the slide on the basis of the patch-level heat map image and the tissue mask image.

Abstract: According to some embodiments of the present disclosure, a display device includes an active pattern including a metal oxide, a gate electrode overlapping the active pattern, a first capacitor electrode spaced apart from the active pattern and including a conductive oxide, and a second capacitor electrode on the first capacitor electrode.

Abstract: The present invention relates to a binder for an anode for a secondary battery, an anode including the binder, and a secondary battery including the anode. More particularly, the present invention relates to a binder for an anode for a secondary battery that has excellent heat resistance and mechanical properties and an improved binding force because a copolymer is used for the binder, and an anode for a secondary battery. In addition, expansion and shrinkage of the anode may be efficiently suppressed, such that charge and discharge life characteristics and performance of the secondary battery may be improved.

Abstract: A system for diagnosing a disease, implemented in a system and which uses a slide of a biological image, and a neural network, includes a patch level segmentation neural network which, for each patch in which the slide is divided into a predetermined size, receives the patch through an input layer and specifies an area in which a disease exists in the patch, wherein the patch level segmentation neural network is provided with a disease diagnosis system including a patch level classification neural network which receives the patch through an input layer and outputs a patch level classification result regarding whether the disease exists in the patch, and a patch level segmentation architecture which receives a feature map generated in each of plural feature extraction layers among hidden layers included in the patch level classification neural network and specifies an area in which a disease exists in the patch.

Abstract: A method executed by a computing entity includes generating a virtual reality environment utilizing a group of object representations by rendering an assessment asset for a first set of object representations to produce first portrayal 3-D video frames of a first piece of information for the virtual reality environment. The method further includes obtaining a first conveyance effectiveness level with regards to the first piece of information based on the first portrayal 3-D video frames within the virtual reality environment. When the first conveyance effectiveness level is less than a minimum conveyance effectiveness threshold level, the method further includes rendering an updated first set of object representations based on the first set of object representations and the first conveyance effectiveness level to produce updated first portrayal 3-D video frames for the first piece of information within the virtual reality environment.

Abstract: The present invention relates to a composition forming nanoparticles for delivering a drug, and more specifically, to a composition for drug delivery comprising nanoparticles containing cationic compounds and a polylactic acid salt but not containing an amphiphilic polymer, wherein a drug can easily be incorporated into the nanoparticles by simply mixing the drug therewith, and furthermore, cell delivery efficiency of the drug can be further increased compared to nanoparticles containing an amphiphilic polymer.

Abstract: The present invention relates to a kit for preparing nanoparticles containing a drug and, more specifically, to a kit for preparing drug-containing nanoparticles, the kit enabling a drug to be easily contained in nanoparticles by simple mixing only, preferably, in a specific weight ratio, the drug and nanoparticles containing a cationic compound and a polylactate, as kit constituent components comprising no amphiphilic polymers, and being designed to enable the efficiency of drug delivery into cells to be greater than that of a kit comprising an amphiphilic polymer.

Abstract: A method executed by a computing entity includes generating a virtual reality environment utilizing a group of object representations by rendering a representation of a first set of object representations and a second set of object representations to produce first portrayal 3-D video frames of a first piece of information for the virtual reality environment. The method further includes determining whether a second piece of information has been selected based on a second cue. When the second piece of information has been selected the method further includes rendering another representation of the second set of object representations and the first set of object representations to produce second portrayal 3-D video frames of the second piece of information for the virtual reality environment.

Abstract: Disclosed is a stable liquid formulation, comprising an antibody or antigen-binding portion thereof, an acetate buffer, glycine, and a surfactant, wherein the stable liquid formulation does not comprise at least one of sugar, a sugar alcohol and a metal salt, and the stable liquid formulation is still stable even upon high antibody content, and is superior in osmolality and viscosity, and subcutaneous administration thereof is possible.

Abstract: Provided are a glass transportation apparatus and a system including the glass transportation apparatus for manufacturing a multi-pane glass unit. The glass transportation apparatus includes a plate including a main surface facing a main surface of a glass pane, a gas blowing device configured to blow a gas towards the main surface of the glass pane such that the main surface of the glass pane is spaced apart from the main surface of the plate, and a conveyer including a belt having an upper surface and a plurality of pulleys configured to circulate the belt.

Abstract: A method for execution by a computing entity for creating a learning tool regarding a topic includes issuing a representation of a first set of physicality assessment assets of a first learning object to a second computing entity. The method further includes obtaining a first assessment response in response to the representation of the first set of physicality assessment assets. The method further includes selecting one of the first learning object and a second learning object as an active learning object based on the first assessment response.

Abstract: A method for setting the motion vector list and the apparatus using the same may include determining the presence of a first motion vector or a second motion vector by a sequential determination process in a first spatial candidate prediction group; and setting the first motion vector or the second motion vector produced through the sequential determination process as the candidate prediction motion vector. Thus, the encoding/decoding time and the complexity can be reduced by restricting the scaling number in a process for scanning the candidate prediction motion vector.

Abstract: The present disclosure provides a display apparatus. The display apparatus includes a light source; a compensating diffraction optical element which reflects a light incident from the light source; and an off-axis reflection diffraction optical element which reflects a light reflected from the compensating diffraction optical element to the outside, wherein the compensating diffraction optical element reflects the light incident from the light source toward the off-axis reflection diffraction optical element while adjusting the reflection angle of the light incident from the light source so as to compensate for the reflection angle distortion of the light reflected from the off-axis reflection diffraction optical element.

Abstract: A method for extracting only a portion stained with a specific dye from a pathology slide stained with a mixed dye in which various types of dyes are mixed, training an artificial neural network, and determining a pathology image stained by using various staining techniques; and a computing system performing same. A neural network learning system generates and learns a learning data set including M pieces of individual learning data (where M is a natural number greater than or equal to 2).

Abstract: A stable liquid pharmaceutical preparation of an anti-influenza virus antibody and, more specifically, a stable liquid pharmaceutical preparation that comprises: (A) an anti-influenza virus antibody or a mixture of two or more different types of anti-influenza virus antibodies; (B) a surfactant; (C) a sugar or a sugar derivative; and (D) an amino acid. The stable liquid pharmaceutical preparation for an anti-influenza virus antibody disclosed herein has excellent storage stability at low temperature (5° C.), room temperature (25° C.), and high temperature (40° C.) and excellent long-term (12 months) storage stability, and may be administered intravenously, intramuscularly, transdermally, subcutaneously, intraperitoneally, topically, or in combinations thereof.

Abstract: According to some embodiments of the present disclosure, a display device includes an active pattern including a metal oxide, a gate electrode overlapping the active pattern, a first capacitor electrode spaced apart from the active pattern and including a conductive oxide, and a second capacitor electrode on the first capacitor electrode.

Abstract: The present invention provides a stable liquid pharmaceutical formulation containing: an antibody or its antigen-binding fragment; a surfactant; a sugar or its derivative; and a buffer. The stable liquid pharmaceutical formulation according to the present invention has low viscosity while containing a high content of the antibody, has excellent long-term storage stability based on excellent stability under accelerated conditions and severe conditions, and may be administered subcutaneously.

Abstract: The present invention provides a stable liquid pharmaceutical formulation containing: an antibody or its antigen-binding fragment; a surfactant; a sugar or its derivative; and a buffer. The stable liquid pharmaceutical formulation according to the present invention has low viscosity while containing a high content of the antibody, has excellent long-term storage stability based on excellent stability under accelerated conditions and severe conditions, and may be administered subcutaneously.

Abstract: A disease diagnosis system uses a slide of a biological image and the neural network, the disease diagnosis system including a patch-level segmentation neural network that receives, for each predetermined patch in which the slide is divided into a predetermined size, the patch as an input layer so as to specify the area in which the disease in the patch exists, wherein the patch-level segmentation neural network comprises: a patch-level classification neural network, which receives the patch as an input layer so as to output a patch-level classification result about whether the disease exists in the patch; and a patch-level segmentation architecture, which receives a feature map generated in each of two or more feature map extraction layers from among hidden layers included in the patch-level classification neural network, so as to specify the area in which the disease in the patch exists.